Coastwise Capital Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Sell |
3,651
-320
| -8% | -$26.5K | 0.24% | 90 |
|
|
2025
Q1 | $322K | Buy |
3,971
+80
| +2% | +$6.49K | 0.27% | 87 |
|
|
2024
Q4 | $350K | Hold |
3,891
| – | – | 0.28% | 81 |
|
|
2024
Q3 | $384K | Buy |
3,891
+100
| +3% | +$9.88K | 0.32% | 80 |
|
|
2024
Q2 | $351K | Sell |
3,791
-1,038
| -21% | -$96.2K | 0.33% | 79 |
|
|
2024
Q1 | $458K | Buy |
4,829
+135
| +3% | +$12.8K | 0.42% | 69 |
|
|
2023
Q4 | $419K | Buy |
4,694
+465
| +11% | +$41.5K | 0.43% | 68 |
|
|
2023
Q3 | $309K | Sell |
4,229
-400
| -9% | -$29.2K | 0.35% | 79 |
|
|
2023
Q2 | $385K | Buy |
4,629
+175
| +4% | +$14.6K | 0.44% | 64 |
|
|
2023
Q1 | $339K | Buy |
4,454
+430
| +11% | +$32.8K | 0.39% | 76 |
|
|
2022
Q4 | $334K | Sell |
4,024
-600
| -13% | -$49.8K | 0.4% | 75 |
|
|
2022
Q3 | $367K | Sell |
4,624
-480
| -9% | -$38.1K | 0.58% | 59 |
|
|
2022
Q2 | $379K | Sell |
5,104
-245
| -5% | -$18.2K | 0.46% | 65 |
|
|
2022
Q1 | $481K | Buy |
+5,349
| New | +$481K | 0.6% | 49 |
|